Scholarlink

<p>Liver disease remains a significant public health problem, claiming several lives globally every year. All forms of liver disease, irrespective of the cause, lead to liver fibrosis if they persist. Liver fibrosis ends up in liver cirrhosis and creates a microenvironment that enhances the development of hepatocellular carcinoma. <i>Clerodendrum volubile</i> is a food and medicinal plant consumed to manage several diseases, including liver diseases. Liver fibrosis was induced in Wistar rats with carbon tetrachloride (CCl<sub>4</sub> Olive oil 1:1) for nine weeks and treated with the extract from weeks 7–9. The activities of liver function markers (ALT, AST, Total and indirect bilirubin), antioxidant enzymes (GSH, SOD, Gpx), level of lipid peroxidation and histopathological lesions were assessed. In silico method was used to investigate the binding affinity of <i>C. volubile</i>-derived phytochemicals to cytochrome 450 2E1. The extract significantly (<i>p</i> &lt; 0.05) reduced CCl<sub>4</sub>-induced ALT, AST, bilirubin and lipid peroxidation, increased the activity (<i>p</i> &lt; 0.05) of GSH, SOD and Gpx, and ameliorated CCl<sub>4</sub>-induced hepatic lesions and collagen deposition. In the in silico study, four <i>C. volubile</i>-derived phytochemicals showed significant binding affinity with CYP2E1, with Phytol showing the best and most stable binding. The study thus predicted the potential of <i>C. volubile</i> to inhibit liver fibrogenesis via antioxidative and anti-CYP2E1 effects.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Inhibitory effect of the methanol extract of Clerodendrum volubile Linn. on carbon tetrachloride-induced early hepatic fibrogenesis: in silico and in vivo study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月19日

查看全文
  • Ifeoluwa Temitayo Oyeyemi,
  • Abiola Mojisola Asowata-Ayodele,
  • Ademola Oluwatobiloba Adetula,
  • Kabirat Adedunmola Sulaiman,
  • Demilade Elizabeth Omape,
  • Muyiwa Samuel Fageyinbo

摘要

Liver disease remains a significant public health problem, claiming several lives globally every year. All forms of liver disease, irrespective of the cause, lead to liver fibrosis if they persist. Liver fibrosis ends up in liver cirrhosis and creates a microenvironment that enhances the development of hepatocellular carcinoma. Clerodendrum volubile is a food and medicinal plant consumed to manage several diseases, including liver diseases. Liver fibrosis was induced in Wistar rats with carbon tetrachloride (CCl4 Olive oil 1:1) for nine weeks and treated with the extract from weeks 7–9. The activities of liver function markers (ALT, AST, Total and indirect bilirubin), antioxidant enzymes (GSH, SOD, Gpx), level of lipid peroxidation and histopathological lesions were assessed. In silico method was used to investigate the binding affinity of C. volubile-derived phytochemicals to cytochrome 450 2E1. The extract significantly (p < 0.05) reduced CCl4-induced ALT, AST, bilirubin and lipid peroxidation, increased the activity (p < 0.05) of GSH, SOD and Gpx, and ameliorated CCl4-induced hepatic lesions and collagen deposition. In the in silico study, four C. volubile-derived phytochemicals showed significant binding affinity with CYP2E1, with Phytol showing the best and most stable binding. The study thus predicted the potential of C. volubile to inhibit liver fibrogenesis via antioxidative and anti-CYP2E1 effects.